A detailed history of Vontobel Holding Ltd. transactions in Io Biotech, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 32,667 shares of IOBT stock, worth $29,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,667
Holding current value
$29,400
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

BUY
$0.68 - $1.33 $22,213 - $43,447
32,667 New
32,667 $30,000

Others Institutions Holding IOBT

About IO Biotech, Inc.


  • Ticker IOBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,815,300
  • Market Cap $25.9M
  • Description
  • IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...
More about IOBT
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.